NO300778B1 - Pseudopeptider, anvendelse derav, samt farmasöytiske preparater inneholdende slike - Google Patents

Pseudopeptider, anvendelse derav, samt farmasöytiske preparater inneholdende slike Download PDF

Info

Publication number
NO300778B1
NO300778B1 NO930830A NO930830A NO300778B1 NO 300778 B1 NO300778 B1 NO 300778B1 NO 930830 A NO930830 A NO 930830A NO 930830 A NO930830 A NO 930830A NO 300778 B1 NO300778 B1 NO 300778B1
Authority
NO
Norway
Prior art keywords
amino
acid
denotes
formula
group
Prior art date
Application number
NO930830A
Other languages
English (en)
Norwegian (no)
Other versions
NO930830L (no
NO930830D0 (no
Inventor
Georg Kottirsch
Rainer Metternich
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of NO930830D0 publication Critical patent/NO930830D0/no
Publication of NO930830L publication Critical patent/NO930830L/no
Publication of NO300778B1 publication Critical patent/NO300778B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
    • C07C311/19—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
    • C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
    • C07C257/18—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30—Oxygen atoms, e.g. delta-lactones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/56—Ring systems containing bridged rings
    • C07C2603/58—Ring systems containing bridged rings containing three rings
    • C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
    • C07C2603/74—Adamantanes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Materials For Medical Uses (AREA)
NO930830A 1992-03-10 1993-03-08 Pseudopeptider, anvendelse derav, samt farmasöytiske preparater inneholdende slike NO300778B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4207544 1992-03-10

Publications (3)

Publication Number Publication Date
NO930830D0 NO930830D0 (no) 1993-03-08
NO930830L NO930830L (no) 1993-09-13
NO300778B1 true NO300778B1 (no) 1997-07-21

Family

ID=6453662

Family Applications (1)

Application Number Title Priority Date Filing Date
NO930830A NO300778B1 (no) 1992-03-10 1993-03-08 Pseudopeptider, anvendelse derav, samt farmasöytiske preparater inneholdende slike

Country Status (26)

Country Link
US (1) US5561112A (cs)
EP (1) EP0560730B1 (cs)
JP (1) JP2860222B2 (cs)
KR (1) KR930019690A (cs)
CN (1) CN1076200A (cs)
AT (1) ATE142618T1 (cs)
AU (1) AU659281B2 (cs)
CA (1) CA2091292A1 (cs)
CZ (1) CZ36193A3 (cs)
DE (1) DE69304573T2 (cs)
DK (1) DK0560730T3 (cs)
ES (1) ES2090934T3 (cs)
FI (1) FI931023L (cs)
GR (1) GR3021030T3 (cs)
HU (2) HUT63609A (cs)
IL (1) IL104972A (cs)
MX (1) MX9301298A (cs)
MY (1) MY109060A (cs)
NO (1) NO300778B1 (cs)
NZ (1) NZ247084A (cs)
PH (1) PH30893A (cs)
RU (1) RU2106356C1 (cs)
SG (1) SG47059A1 (cs)
SK (1) SK17093A3 (cs)
TW (1) TW256828B (cs)
ZA (1) ZA931724B (cs)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU692438B2 (en) * 1993-03-29 1998-06-11 Astrazeneca Ab Heterocyclic derivatives as platelet aggregation inhibitors
US5652242A (en) * 1993-03-29 1997-07-29 Zeneca Limited Heterocyclic derivatives
US5753659A (en) * 1993-03-29 1998-05-19 Zeneca Limited Heterocyclic compouds
US5750754A (en) * 1993-03-29 1998-05-12 Zeneca Limited Heterocyclic compounds
WO1994022835A2 (en) * 1993-03-29 1994-10-13 Zeneca Limited Heterocyclic compounds as platelet aggregation inhibitors
DE4310643A1 (de) * 1993-04-01 1994-10-06 Merck Patent Gmbh Cyclische Adhäsionsinhibitoren
GB9313285D0 (en) * 1993-06-28 1993-08-11 Zeneca Ltd Acid derivatives
GB9313268D0 (en) * 1993-06-28 1993-08-11 Zeneca Ltd Chemical compounds
US5463011A (en) * 1993-06-28 1995-10-31 Zeneca Limited Acid derivatives
US5811398A (en) * 1995-04-11 1998-09-22 G. D. Searle & Co. Platelet aggregation inhibitors containing C-terminal aminergic side chain amino acid residues
EP0892780B1 (en) * 1996-02-22 2002-11-20 Bristol-Myers Squibb Pharma Company M-AMIDINO PHENYL ANALOGS AS FACTOR Xa INHIBITORS
US5942544A (en) * 1996-02-22 1999-08-24 Dupont Pharmaceuticals Company α-branched anilines, toluenes, and analogs thereof as factor Xa inhibitors
RU2142939C1 (ru) * 1996-10-28 1999-12-20 Эл Джи Кемикал Лтд. Избирательно действующие ингибиторы тромбина и фармацевтическая композиция на их основе
EP1478405A2 (en) * 2002-01-28 2004-11-24 Novartis AG Beta-homolysine conjugates and their use as transport enhancer

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4578079A (en) * 1982-08-04 1986-03-25 La Jolla Cancer Research Foundation Tetrapeptide
WO1988007867A1 (en) * 1987-04-08 1988-10-20 Nippon Shinyaku Co., Ltd. Nootropic
IT1222437B (it) * 1987-08-04 1990-09-05 Ellem Ind Farmaceutica Tripeptidi utili come immunostimolanti e nella prevenzione delle metastasi e relativo procedimento di preparazione
US4879313A (en) * 1988-07-20 1989-11-07 Mosanto Company Novel platelet-aggregation inhibitors
US5037808A (en) * 1988-07-20 1991-08-06 Monsanto Co. Indolyl platelet-aggregation inhibitors
US5039805A (en) * 1988-12-08 1991-08-13 Hoffmann-La Roche Inc. Novel benzoic and phenylacetic acid derivatives
CA2037153A1 (en) * 1990-03-09 1991-09-10 Leo Alig Acetic acid derivatives
US5273982A (en) * 1990-03-09 1993-12-28 Hoffmann-La Roche Inc. Acetic acid derivatives
US5354738A (en) * 1992-09-04 1994-10-11 G. D. Searle & Co. Platelet aggregation inhibitors

Also Published As

Publication number Publication date
GR3021030T3 (en) 1996-12-31
PH30893A (en) 1997-12-23
HU210878A9 (en) 1995-09-28
CZ36193A3 (en) 1994-01-19
HUT63609A (en) 1993-09-28
EP0560730A3 (en) 1993-12-01
AU3406993A (en) 1993-09-16
FI931023A7 (fi) 1993-09-11
IL104972A (en) 1998-04-05
NO930830L (no) 1993-09-13
HU9300501D0 (en) 1993-05-28
JP2860222B2 (ja) 1999-02-24
ATE142618T1 (de) 1996-09-15
DE69304573T2 (de) 1997-03-20
EP0560730A2 (en) 1993-09-15
MX9301298A (es) 1993-10-01
AU659281B2 (en) 1995-05-11
ZA931724B (en) 1994-09-10
FI931023L (fi) 1993-09-11
JPH0665175A (ja) 1994-03-08
MY109060A (en) 1996-11-30
CA2091292A1 (en) 1993-09-11
KR930019690A (ko) 1993-10-18
DE69304573D1 (de) 1996-10-17
EP0560730B1 (en) 1996-09-11
SK17093A3 (en) 1993-10-06
DK0560730T3 (da) 1996-10-28
FI931023A0 (fi) 1993-03-08
RU2106356C1 (ru) 1998-03-10
IL104972A0 (en) 1993-07-08
CN1076200A (zh) 1993-09-15
ES2090934T3 (es) 1996-10-16
SG47059A1 (en) 1998-03-20
NZ247084A (en) 1995-09-26
US5561112A (en) 1996-10-01
NO930830D0 (no) 1993-03-08
TW256828B (cs) 1995-09-11

Similar Documents

Publication Publication Date Title
US5430024A (en) Peptides bearing N-terminal amidino moieties and their use as inhibitors of platelet aggregation
AU643036B2 (en) Dipeptide derivatives
AU648751B2 (en) Novel aminobenzoates
US5399585A (en) Carboxamides and sulfonamides compounds which have useful pharmaceutical utility
US5552431A (en) Peptide mimetic compounds useful as platelet aggregation inhibitors
IL97401A (en) Acetic acid derivatives, their preparation and pharmaceutical compositions containing them.
NO300778B1 (no) Pseudopeptider, anvendelse derav, samt farmasöytiske preparater inneholdende slike
US6235717B1 (en) Pharmaceutical compounds
NO900839L (no) Glycinderivater.
US4985407A (en) Dipeptide compounds, processes for their preparation and compositions containing them
US5344837A (en) Platelet aggregation inhibitors
AU3819999A (en) Certain thiol inhibitors of endothelin-converting enzyme
US5798370A (en) Platelet aggregation inhibitors
US6268380B1 (en) Urea derivatives useful as platelet aggregation inhibitors
WO1994020457A1 (en) N-acyl beta amino acid derivatives useful as platelet aggregation inhibitors
EP1864995B1 (en) Beta-lactamic rgd cyclopeptides containing gamma turns
US5625093A (en) Substituted β-amino acid derivatives useful as platelet aggregation inhibitors
KR100798560B1 (ko) 페린도프릴 및 이들의 약제학적 허용 염의 합성을 위한방법
US20070037845A1 (en) Peptido-mimetic compounds containing rgd sequence useful as integrin inhibitors, and intermediates thereof
US5811398A (en) Platelet aggregation inhibitors containing C-terminal aminergic side chain amino acid residues
JPH0797393A (ja) 新規エンドセリン拮抗性ペプチド